These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 3088491)

  • 21. Clinical practice. Monoclonal gammopathy of undetermined significance.
    Bladé J
    N Engl J Med; 2006 Dec; 355(26):2765-70. PubMed ID: 17192542
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].
    Youinou P; Le Goff P; Saleun JP; Jouquan J; Tymen G; Le Menn G
    Pathol Biol (Paris); 1977 Oct; 25(8):517-21. PubMed ID: 413086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunochemical and clinical characteristic of series of 516 paraproteinemic patients.
    Tichý M; Hrncir Z; Mracek J; Hrncirová L; Matĕja F
    Neoplasma; 1978; 25(4):477-81. PubMed ID: 99675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal gammopathy and osteolytic lesions as the initial manifestation of a metastatic hypernephroma].
    Castillo Jimeno JM; Illarramendi Mañas JJ; Ruiz Rubio JL; Santiago González A; Sebastián Borruel JL
    Arch Esp Urol; 1991 Nov; 44(9):1110-2. PubMed ID: 1807217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum protein immunofixation in malignant hemopathies other than multiple myeloma and Waldenstrom's macroglobulinemia].
    Ramont L; Ngoc PT; Pignon B; Maquart FX
    Ann Biol Clin (Paris); 2002; 60(5):565-70. PubMed ID: 12368142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The OKT4/OKT8 ratio in benign monoclonal gammopathies].
    La Rosa L; Mattoni C; La Rosa M
    Minerva Med; 1988 Dec; 79(12):1049-50. PubMed ID: 2974933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The monoclonal gammapathy of uncertain meaning- a premyelomatosis?].
    Kühn RA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):312-6. PubMed ID: 2428705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current role of the laboratory in the demonstration and follow up of monoclonal immunoglobulinopathy].
    Myara I
    Pathol Biol (Paris); 1990 Feb; 38(2):134-43. PubMed ID: 2107510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic significance of kappa/lambda and lambda/kappa ratio in paraproteinemias.
    Tichý M; Hrncír Z
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1982; 25(3-4):313-8. PubMed ID: 6820852
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens.
    Peest D; Gasch S; Thiele C; Bartels B; Brunkhorst U; Dallmann I; Hoffmann M; Schedel I; Deicher H
    Clin Exp Immunol; 1986 Jul; 65(1):120-7. PubMed ID: 3098470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoregulatory cells in patients with monoclonal gammopathies].
    Kuriyama Y; Kawanishi Y; Iwase O; Nakano M; Toyama K
    Rinsho Ketsueki; 1994 Jul; 35(7):642-8. PubMed ID: 7914943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IgM monoclonal gammopathy in plasmacytic neoplasms].
    Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S
    Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in helper (T4+) lymphocytes following cimetidine treatment for duodenal ulcer.
    Hast R; Bernell P; Befrits R; Dowding C; Sjögren AM
    Clin Exp Immunol; 1986 Apr; 64(1):114-8. PubMed ID: 2942318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.